A LinkedIn post from Okami Medical highlights clinical use of its LOBO embolization system in a renal arteriovenous malformation procedure. According to the post, interventional radiologist Dr. Mohammed Loya achieved rapid vessel occlusion using a single device per vessel in this case.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post describes the use of LOBO-9 delivered through the SENDERO MAX platform, followed by telescoping a 2.8 microcatheter through SENDERO MAX to place a LOBO-3 in a second feeding branch. This suggests the technology may support streamlined workflows and device efficiency in complex embolization procedures.
For investors, the example may indicate growing physician adoption and real-world validation of the LOBO platform in renal AVM interventions. Increased clinical utilization and positive case exposure in interventional radiology could strengthen Okami Medical’s positioning in the MedTech embolization market and support future commercialization efforts.